A contribution to detection of anticardiolipin and anti-β2glycoprotein I antibodies: Comparison between a home-made ELISA and a fluorescence enzyme immunoassay

Clinica Chimica Acta

Volumn 446, Issue , 2015, Pages 93-

  Mattia, Elena ^a   Ruffatti, Amelia ^a   Meneghel, Lauro ^a   Tonello, Marta ^a   Faggian, Diego ^a   Hoxha, Ariela ^a   Fedrigo, Marny ^a   Punzi, Leonardo ^a   Plebani, Mario ^a  

^a UNIVERSITY OF PADOVA   (Italy)

Author keywords

Anti 2glycoprotein I antibodies; Anticardiolipin antibodies; ELISA; Fluorescence enzyme immunoassay; Primary antiphospholipid syndrome

Indexed keywords

BETA2 GLYCOPROTEIN 1 ANTIBODY; CARDIOLIPIN ANTIBODY; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY; BETA2 GLYCOPROTEIN 1; BIOLOGICAL MARKER;

ADULT; AGED; ANTIBODY BLOOD LEVEL; ANTIBODY DETECTION; ANTIPHOSPHOLIPID SYNDROME; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; ENZYME IMMUNOASSAY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLUORESCENCE ENZYME IMMUNOASSAY; HUMAN; IMMUNOLOGY TEST KIT; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; ADOLESCENT; BLOOD; COHORT ANALYSIS; FLUORESCENCE; MIDDLE AGED; PROCEDURES; STANDARDS; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; ANTIBODIES, ANTICARDIOLIPIN; ANTIPHOSPHOLIPID SYNDROME; BETA 2-GLYCOPROTEIN I; BIOMARKERS; COHORT STUDIES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FLUORESCENCE; HUMANS; IMMUNOENZYME TECHNIQUES; MALE; MIDDLE AGED; YOUNG ADULT;

EID: 84928335529     PISSN: 00098981     EISSN: 18733492     Source Type: Journal    
DOI: 10.1016/j.cca.2015.04.012     Document Type: Article

References (19)

1. Miyakis S., Lockshin M.D., Atsumi T., et al. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost 2006, 4:295-306.
2. Devreese K.M.J., Pierangeli S.S., De Laat B., Tripodi A., Atsumi T., Ortel T.L. For the Subcommittee on Lupus Anticoagulant/Phospholipid/Dependent Antibodies. Testing for Antiphospholipid Antibodies with Solid Phase Assays: Guidance from the SSC of the ISTH. J Thromb Haemost 2014, 12:792-795.
3. Ruffatti A., Olivieri S., M.Tonello, et al. Influence of different IgG anticardiolipin antibody cut-off values on antiphospholipid syndrome classification. J. Thromb. Haemost. 2008, 6:1693-1696.
4. Pengo V., Tripodi A., Reber G., et al. Update of the guidelines for lupus anticoagulant detection. Subcommittee on Lupus Anticoagulant/Antiphospholipid Antibody of the Scientific and Standardisation Committee of the International Society on Thrombosis and Haemostasis. J Thromb Haemost 2009, 7:1737-1740.
5. Favaloro E.J., Plebani M., Lippi G. Standardization and harmonization of antiphospholipid antibody assays. Semin Thromb Hemost 2014, 40:161-162.
6. Tincani A., Filippini M., Scarsi M., et al. European attempts for the standardisation of antiphospholipid antibodies. Lupus 2009, 18:913-919.
7. Tincani A., Allegri F., Balestrieri G., et al. Minimal requirements for antiphospholipid antibodies ELISAs proposed by the European Forum on antiphospholipid antibodies. Thromb Res 2004, 114:553-558.
8. Reber G., Tincani A., Sanmarco M., de Moerloose P., Boffa M.C. Proposals for the measurement of anti-b2-glycoprotein I antibodies. Standardization Group of the European Forum on Antiphospholipid Antibodies. J Thromb Haemost 2004, 2:1860-1862.
9. Harris E.N., Pierangeli S.S. Revisiting the anticardiolipin test and its standardization. Lupus 2002, 11:269-275.
10. Forastiero R., Papalardo E., Watkins M., et al. Evaluation of different immunoassays for the detection of antiphospholipid antibodies: Report of a Wet Workshop During the 13th International Congress on Antiphospholipid Antibodies. Clin Chim Acta 2014, 428:99-105.
11. Montaruli B., De Luna E., Mengozzi G., et al. Anti-cardiolipin and anti-β2-glycoprotein I antibodies: normal reference ranges in north western Italy. Lupus 2012, 21:799-801.
12. Damoiseaux J., Peeters L., Hupperts R., Boreas A., ten Cate H., Cohen Tervaert J.W. Prevalence of anticardiolipin antibodies in patient cohort with distinct clinical manifestations of the antiphospholipid syndrome. Ann N Y Acad Sci 2009, 1173:146-151.
13. Villalta D., Alessio M.G., Tampoia M., et al. Accuracy of the first fully automated method for anti-cardiolipin anti-beta2 glycoprotein I antibody detection for the diagnosis of antiphospholipid syndrome. Ann N Y Acad Sci 2009, 1173:21-27.
14. Andreoli L., Rizzini S., Allegri F., Meroni P., Tincani A. Are the current attempts at standardization of antiphospholipid antibodies still useful? Emerging technologies signal a shift in direction. Semin Thromb Hemost 2008, 34:356-360.
15. Defining, establishing and verifying reference intervals in the clinical laboratory; approved guideline 2008, Clinical and Laboratory Standards Institute, Wayne, PA, [C28-A3]. 3rd ed.
16. Pierangeli S.S., Harris E.N. Clinical laboratory testing for the antiphospholipid syndrome. Clin Chim Acta 2005, 357:17-33.
17. Ichikawa K., Tsutsumi A., Atsumi T., et al. A chimeric antibody with the human gamma1 constant region as a putative standard for assays to detect IgG beta2-glycoprotein I-dependent anticardiolipin and anti-beta2-glycoprotein I antibodies. Arthritis Rheum 1999, 42:2461-2470.
18. Viera A.J., Garrett J.M. Understanding interobserver agreement: the kappa statistic. Fam Med 2005, 37:360-363.
19. Galli M., Reber G., de Moerloose P., de Groot P.G. Invitation to a debate on the serological criteria that define the antiphospholipid syndrome. J Thromb Haemost 2008, 6:399-401.